NCT07131956View on ClinicalTrials.gov

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Prostate Cancer (Diagnosis)Prostate Cancer Patients Who Have Brachytherapy Seed ImplantProstate Cancer Patients Treated by RadiotherapyProstate Cancer Recurrent
Trial Locations (3)

81377

NOT_YET_RECRUITING

Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Munich

86156

NOT_YET_RECRUITING

Klinik für Strahlentherapie, Augsburg

91054

RECRUITING

Strahlenklinik Erlangen, Erlangen

All Listed Sponsors
collaborator

Bavarian Cancer Research Center (BZKF)

UNKNOWN

collaborator

University Hospital Augsburg

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT07131956 - Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | Biotech Hunter | Biotech Hunter